Marker Therapeutics, Inc.
MRKR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001094038
No open-market purchases or sales by Marker Therapeutics, Inc. insiders were filed in the last 90 days; 35 institutions reported holding it in 13F filings for Q2 2026, worth $5.84M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Marker Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +2 vs. Q4 2023
- Shares held
- 1.98M
- +4.55K (+0.2%) vs. Q4 2023
- Total value
- $8.52M
- −$2.35M (−21.6%) vs. Q4 2023
- New holders
- 3
- 8 more added
- Sold out
- 1
- 6 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MRKR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $5.84M |
| Q1 2026 | 35 | $5.07M |
| Q4 2025 | 36 | $6.03M |
| Q3 2025 | 32 | $3.09M |
| Q2 2025 | 31 | $5.22M |
| Q1 2025 | 32 | $5.04M |
| Q4 2024 | 33 | $11.0M |
| Q3 2024 | 28 | $5.67M |
| Q2 2024 | 28 | $10.9M |
| Q1 2024 | 28 | $8.52M |
| Q4 2023 | 26 | $10.9M |
| Q3 2023 | 28 | $8.82M |
| Q2 2023 | 29 | $5.78M |
| Q1 2023 | 30 | $1.41M |
| Q4 2022 | 48 | $5.21M |
| Q3 2022 | 47 | $7.54M |
| Q2 2022 | 50 | $7.35M |
| Q1 2022 | 52 | $10.3M |
| Q4 2021 | 65 | $25.1M |
| Q3 2021 | 63 | $44.7M |
| Q2 2021 | 74 | $75.8M |
| Q1 2021 | 74 | $56.9M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Marker Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 15 | $0 | 0.00% | −16−51.6% | Reduced |
| FMR LLC | 12 | $52 | 0.00% | 00.0% | Unchanged |
| Versant Capital Management, Inc | 15 | $65 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 38 | $164 | 0.00% | +5+15.2% | Added |
| Hilltop National Bank | 73 | $314 | 0.00% | +73 | New |
| Group One Trading, L.P. | 178 | $765 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 284 | $1.22K | 0.00% | +1+0.4% | Added |
| UBS Group AG | 427 | $1.84K | 0.00% | +427 | New |
| US Bancorp | 839 | $3.61K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 992 | $4.27K | 0.00% | −372−27.3% | Reduced |
| Tower Research Capital LLC (TRC) | 1,333 | $5.73K | 0.00% | +21+1.6% | Added |
| Riggs Asset Managment Co. Inc. | 1,400 | $6.02K | 0.00% | −200−12.5% | Reduced |
| Bank of America Corp | 2,562 | $11.0K | 0.00% | +228+9.8% | Added |
| Morgan Stanley | 4,040 | $17.4K | 0.00% | +442+12.3% | Added |
| Advisor Group Holdings, Inc. | 8,585 | $36.9K | 0.00% | +2,200+34.5% | Added |
| Susquehanna International Group, LLP | 14,817 | $63.7K | 0.00% | +14,817 | New |
| Matrix Asset Advisors Inc | 15,000 | $64.5K | 0.01% | 00.0% | Unchanged |
| Creative Planning | 17,312 | $74.4K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 19,748 | $84.9K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 20,278 | $87.2K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 34,823 | $149.7K | 0.00% | −3,888−10.0% | Reduced |
| Renaissance Technologies LLC | 37,250 | $160.0K | 0.00% | −300−0.8% | Reduced |
| Wedbush Securities Inc | 45,500 | $196.0K | 0.01% | −24,000−34.5% | Reduced |
| Geode Capital Management, LLC | 67,053 | $288.4K | 0.00% | +7,006+11.7% | Added |
| Ar Asset Management Inc | 70,700 | $304.0K | 0.07% | 00.0% | Unchanged |
| Vanguard Group Inc | 233,231 | $1.00M | 0.00% | +8,174+3.6% | Added |
| Aisling Capital Management LP | 314,286 | $1.35M | 0.46% | 00.0% | Unchanged |
| NEA Management Company, LLC | 1,071,428 | $4.61M | 0.29% | 00.0% | Unchanged |
| Huntington National Bank | 0 | $0 | 0.00% | −70−100.0% | Sold out |